NCT03309514View on ClinicalTrials.gov

Transplantation of Neural Stem Cell-Derived Neurons for Parkinson's Disease

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

June 30, 2024

Conditions
Parkinson's Disease
Interventions
BIOLOGICAL

Intracerebral microinjections

Stereotactic delivery of cell suspension into basal ganglia structures

Sponsors

Lead Sponsor

NeuroGeneration
All Listed Sponsors
lead

NeuroGeneration

INDUSTRY